nirogacestatum 100 mg ut nirogacestatum dihydrobromidum 133.049 mg, cellulosum microcristallinum, lactosum monohydricum 115.65 mg, carboxymethylamylum natricum A corresp. natrium max. 1.1 mg, magnesii stearas, Überzug: copolymerum macrogolo et alcoholi poly(vinylico) constatum, talcum, E 171, glyceroli mono/dicaprylocapras, poly(alcohol vinylicus), E 110 0.09 mg, E 172 (flavum), pro compresso obducto.
Packungsbestandteile
Coated tablets
Active Agent
Dose
Nirogacestatum
100 mg
Inactive agents
Dose
additional_information
(Flavum)
Carboxymethylamylum Natricum A
Cellulosum Microcristallinum
Copolymerum Macrogolo et Alcoholi Poly(Vinylico) Constatum
Überzug
E 110
0.09 mg
color.
E 171
color.
E 172
color.
Glyceroli Mono/dicaprylocapras
Lactose Monohydrate
115.65 mg
Magnesii Stearas
Poly(Alcohol Vinylicus)
Pro Compresso Obducto
Talcum
Source
Data was imported : 08.07.2026
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
